Harmel Rayat

Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.

NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC.

Montgomery Asset Management Corp. provides financial consulting services. The company is headquartered in Vancouver, Canada.

MicroChannel Technologies Corp. is a development stage company. It is not engaged in any business operations. The company was founded on February 28, 2005 and is headquartered in Fort Lauderdale, FL.

Kalen Capital Corp. provides investment advisory services. The private company is based in Vancouver, CA. and has subsidiaries in the United States. The Canadian company was founded by Harmel S. Rayat, who has been the CEO since incorporation.